Schiffmann S - Search Results

1

Immunogenicity assay development and validation for biological therapy as exemplified by ustekinumab.

Mojtahed Poor S, Ulshöfer T, Gabriel LA, Henke M, Köhm M, Behrens F, Geisslinger G, Parnham MJ, Burkhardt H, Schiffmann S. Mojtahed Poor S, et al. Among authors: schiffmann s. Clin Exp Immunol. 2019 May;196(2):259-275. doi: 10.1111/cei.13261. Epub 2019 Feb 3. Clin Exp Immunol. 2019. PMID: 30656642 Free PMC article.

2

Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.

Janssen A, Maier TJ, Schiffmann S, Coste O, Seegel M, Geisslinger G, Grösch S. Janssen A, et al. Among authors: schiffmann s. Eur J Pharmacol. 2006 Jul 1;540(1-3):24-33. doi: 10.1016/j.ejphar.2006.04.030. Epub 2006 May 3. Eur J Pharmacol. 2006. PMID: 16730702

3

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.

Grösch S, Maier TJ, Schiffmann S, Geisslinger G. Grösch S, et al. Among authors: schiffmann s. J Natl Cancer Inst. 2006 Jun 7;98(11):736-47. doi: 10.1093/jnci/djj206. J Natl Cancer Inst. 2006. PMID: 16757698 Review.

4

p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells.

Janssen A, Schiffmann S, Birod K, Maier TJ, Wobst I, Geisslinger G, Grösch S. Janssen A, et al. Among authors: schiffmann s. Biochem Biophys Res Commun. 2008 Jan 25;365(4):698-703. doi: 10.1016/j.bbrc.2007.11.051. Epub 2007 Nov 26. Biochem Biophys Res Commun. 2008. PMID: 18036557

5

Dimethylcelecoxib inhibits prostaglandin E2 production.

Wobst I, Schiffmann S, Birod K, Maier TJ, Schmidt R, Angioni C, Geisslinger G, Grösch S. Wobst I, et al. Among authors: schiffmann s. Biochem Pharmacol. 2008 Jul 1;76(1):62-9. doi: 10.1016/j.bcp.2008.04.008. Epub 2008 Apr 24. Biochem Pharmacol. 2008. PMID: 18508034

6

The anti-proliferative potency of celecoxib is not a class effect of coxibs.

Schiffmann S, Maier TJ, Wobst I, Janssen A, Corban-Wilhelm H, Angioni C, Geisslinger G, Grösch S. Schiffmann S, et al. Biochem Pharmacol. 2008 Jul 15;76(2):179-87. doi: 10.1016/j.bcp.2008.04.017. Epub 2008 May 4. Biochem Pharmacol. 2008. PMID: 18547544

7

Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype.

Weigert A, Schiffmann S, Sekar D, Ley S, Menrad H, Werno C, Grosch S, Geisslinger G, Brüne B. Weigert A, et al. Among authors: schiffmann s. Int J Cancer. 2009 Nov 1;125(9):2114-21. doi: 10.1002/ijc.24594. Int J Cancer. 2009. PMID: 19618460

8

Cellular membranes function as a storage compartment for celecoxib.

Maier TJ, Schiffmann S, Wobst I, Birod K, Angioni C, Hoffmann M, Lopez JJ, Glaubitz C, Steinhilber D, Geisslinger G, Grösch S. Maier TJ, et al. Among authors: schiffmann s. J Mol Med (Berl). 2009 Oct;87(10):981-93. doi: 10.1007/s00109-009-0506-8. Epub 2009 Jul 30. J Mol Med (Berl). 2009. PMID: 19641861

9

Inhibitors of specific ceramide synthases.

Schiffmann S, Hartmann D, Fuchs S, Birod K, Ferreiròs N, Schreiber Y, Zivkovic A, Geisslinger G, Grösch S, Stark H. Schiffmann S, et al. Biochimie. 2012 Feb;94(2):558-65. doi: 10.1016/j.biochi.2011.09.007. Epub 2011 Sep 17. Biochimie. 2012. PMID: 21945810

10

Chain length-specific properties of ceramides.

Grösch S, Schiffmann S, Geisslinger G. Grösch S, et al. Among authors: schiffmann s. Prog Lipid Res. 2012 Jan;51(1):50-62. doi: 10.1016/j.plipres.2011.11.001. Epub 2011 Nov 25. Prog Lipid Res. 2012. PMID: 22133871 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

254 results

Search Page

Filters